Similarly, STAT3 inhibition diminished the mammary carcinoma incidence and decreased the tumor size and aggressiveness; also, minor ObR expression and high levels of miR-200c and Cdh1 were observed in tumor tissue [159]. This evidence concerns the gene STAT3 and neoplasm.